These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 28230646)

  • 1. Effect of Calcineurin Inhibitor-Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart Transplantation.
    Nelson LM; Andreassen AK; Andersson B; Gude E; Eiskjær H; Rådegran G; Dellgren G; Gullestad L; Gustafsson F
    Transplantation; 2017 Nov; 101(11):2793-2800. PubMed ID: 28230646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial.
    Bollano E; Andreassen AK; Eiskjaer H; Gustafsson F; Rådegran G; Gude E; Gullestad L; Broch K; Halden TAS; Karason K; Bartfay SE; Bergh N;
    J Heart Lung Transplant; 2024 Jul; ():. PubMed ID: 39038562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Conversion to Everolimus Within 180 Days of Living Donor Liver Transplantation.
    Rudzik KN; Schonder KS; Humar A; Johnson HJ
    Clin Transplant; 2024 Jul; 38(7):e15402. PubMed ID: 39023099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Everolimus Initiation and Corticosteroid Weaning During Acute Phase After Heart Transplantation on Clinical Outcome: Data from the Korean Organ Transplant Registry (KOTRY).
    Lee KS; Kim H; Lee SH; Choi DJ; Yoon M; Jeon ES; Choi JO; Kang J; Lee HY; Jung SH; Oh J; Kang SM; Lee SY; Ju MH; Kim JJ; Kim MS; Cho HJ
    Transpl Int; 2024; 37():11878. PubMed ID: 38644935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative assessment of renal function utilizing albuminuria in pediatric heart transplant recipients.
    Frandsen EL; Kronmal RA; Albers EA; Friedland-Little JM; Hong BJ; Spencer KL; Hingorani SR; Law YM
    Clin Transplant; 2024 Feb; 38(2):e15253. PubMed ID: 38369813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysis.
    Cornu C; Dufays C; Gaillard S; Gueyffier F; Redonnet M; Sebbag L; Roussoulières A; Gleissner CA; Groetzner J; Lehmkuhl HB; Potena L; Gullestad L; Cantarovich M; Boissonnat P
    Br J Clin Pharmacol; 2014 Jul; 78(1):24-32. PubMed ID: 24251918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Everolimus for Maintenance Immunosuppression of Kidney Transplantation: A Meta-Analysis of Randomized Controlled Trials.
    Liu J; Liu D; Li J; Zhu L; Zhang C; Lei K; Xu Q; You R
    PLoS One; 2017; 12(1):e0170246. PubMed ID: 28107397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of everolimus in liver transplantation.
    Yee ML; Tan HH
    World J Hepatol; 2017 Aug; 9(23):990-1000. PubMed ID: 28878864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma.
    Kang I; Lee JG; Choi SH; Kim HJ; Han DH; Choi GH; Kim MS; Choi JS; Kim SI; Joo DJ
    Clin Mol Hepatol; 2021 Oct; 27(4):589-602. PubMed ID: 34293849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus plus reduced calcineurin inhibitor prevents
    Arns W; Philippe A; Ditt V; Hauser IA; Thaiss F; Sommerer C; Suwelack B; Dragun D; Hillen J; Schiedel C; Elsässer A; Nashan B
    Front Transplant; 2023; 2():1264903. PubMed ID: 38993866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired Microcirculation in Children After Kidney Transplantation: Everolimus Versus Mycophenolate Based Immunosuppression Regimen.
    Ruben S; Kreuzer M; Büscher A; Büscher R; Thumfart J; Querfeld U; Staude H; Ahlenstiel-Grunow T; Melk A; Fischer DC; Leifheit-Nestler M; Pape L; Haffner D
    Kidney Blood Press Res; 2018; 43(3):793-806. PubMed ID: 29807363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Variants in Calcineurin Inhibitor Pharmacokinetic and Pharmacodynamic Genes and Renal Dysfunction in Adult Heart Transplant Recipients.
    Oreschak K; Saba LM; Rafaels N; Ambardekar AV; Deininger KM; Page RL; Lindenfeld J; Aquilante CL
    Front Genet; 2021; 12():658983. PubMed ID: 33868389
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative magnetic resonance imaging indicates brain tissue alterations in patients after liver transplantation.
    Goede LL; Pflugrad H; Schmitz B; Lanfermann H; Tryc AB; Barg-Hock H; Klempnauer J; Weissenborn K; Ding XQ
    PLoS One; 2019; 14(9):e0222934. PubMed ID: 31553760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The decline in kidney function after heart transplantation and its impact on survival.
    Chaemchoi T; Ittiwattanakul W; Ritteeverakul P; Intrarakamhang AL; Thammanatsakul K; Sinphurmsukskul S; Siwamogsatham S; Puwanant S; Ariyachaipanich A
    Clin Transplant; 2023 Dec; 37(12):e15112. PubMed ID: 37676472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How calcineurin inhibitors affect cognition.
    Thiankhaw K; Chattipakorn N; Chattipakorn SC
    Acta Physiol (Oxf); 2024 Jul; 240(7):e14161. PubMed ID: 38747643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin inhibitors: a double-edged sword.
    Ume AC; Wenegieme TY; Williams CR
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F336-F341. PubMed ID: 33225712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus-Induced Immune Effects after Heart Transplantation: A Possible Tool for Clinicians to Monitor Patients at Risk for Transplant Rejection.
    Klaeske K; Lehmann S; Palitzsch R; Büttner P; Barten MJ; Jawad K; Eifert S; Saeed D; Borger MA; Dieterlen MT
    Life (Basel); 2021 Dec; 11(12):. PubMed ID: 34947904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial.
    Gamero MT; Brailovsky Y; Eisen HJ
    J Heart Lung Transplant; 2024 Aug; ():. PubMed ID: 39159701
    [No Abstract]   [Full Text] [Related]  

  • 19. Everolimus-Related Chylothorax: A Rare Case Report.
    Yazdalı Köylü N; Koç NS; Sancar EN; Sarınç S; Altun B
    Exp Clin Transplant; 2024 Jun; 22(6):471-474. PubMed ID: 39072520
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.